Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...
FORT LEE, N.J., July 27, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating ...
BROOMFIELD, Colo., July 21, 2026 (GLOBE NEWSWIRE)-- Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary ...
Incyte (Nasdaq:INCY) today announced that data from key programs in its Hematology and Oncology franchises will be presented at the European Hematology Association (EHA) 2026 Congress, to be held June ...
WALTHAM, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines ...
Reflecting the Company's continuing research into expanding the capabilities of the PAS across early detection applications, the accepted abstracts include: PanGIA Analysis System, a novel machine ...
Please Note: The submission website supports the latest version of Chrome, the current and previous release of Firefox, Safari and Microsoft browsers. Cookies and ...
Missed the Spring Conference deadline? There is one “final call” for you to present your work this semester! Carefully review the information about this session. You can choose to deliver a poster or ...
Week-48 suppression was 91.8% with DOR/ISL vs 90.6% with BIC/FTC/TAF, with few discontinuations for inefficacy and similar overall tolerability. EMBRACE reported 12-month suppression rates of 94% (IV ...
Matthews is a fellow of science and technology policy at Rice University’s Baker Institute for Public Policy. Russell is the Huffington fellow in child health and L.E. Simmons senior fellow in health ...
This page provides answers to the most commonly asked questions regarding abstract submission, confidentiality, and presentation policies. Questions are listed together at the top of the page for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results